Info@ThinkPinkRocks.com

Lilly, ImaginAb partner to study potential novel T-cell-based immuno-oncology therapies

Eli Lilly and Company and ImaginAb Inc. are pleased to announce a preclinical research collaboration to study potential novel T-cell-based immuno-oncology therapies.

Read More:
Lilly, ImaginAb partner to study potential novel T-cell-based immuno-oncology therapies

Share

Leave a Reply